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BACKGROUND: Metastatic melanoma requires early detection, being treatment resistant. However, the earliest events of melanoma
metastasis, and especially of dermal invasion, remain ill defined.
RESULTS AND METHODS: Gene expression profiles of two clonal subpopulations, selected from the same human melanoma cell line, but
differing in ability to cross the dermal–epidermal junction in skin reconstructs, were compared by oligonucleotide microarray. Of
26496 cDNA probes, 461 were differentially expressed (42-fold; Po 0.001), only 71 genes being upregulated in invasive cells.
Among them, TSPAN8, a tetraspanin not yet described in melanoma, was upregulated at mRNA and protein levels in melanoma cells
from the invasive clone, as assessed by RT–PCR, flow cytometry and western blot analysis. Interestingly, TSPAN8 was the only
tetraspanin in which overexpression correlated with invasive phenotype. Flow cytometry of well-defined melanoma cell lines
confirmed that TSPAN8 was exclusively expressed by invasive, but not non-invasive melanoma cells or normal melanocytes.
Immunohistochemistry revealed that TSPAN8 was expressed by melanoma cells in primary melanomas and metastases, but not
epidermal cells in healthy skin. The functional role of TSPAN8 was demonstrated by silencing endogenous TSPAN8 with siRNA,
reducing invasive outgrowth from tumour spheroids within matrigel without affecting cell proliferation or survival.
CONCLUSION: TSPAN8 expression may enable melanoma cells to cross the cutaneous basement membrane, leading to dermal
invasion and progression to metastasis. TSPAN8 could be a promising target in early detection and treatment of melanoma.
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Melanoma is the leading cause of death of all skin diseases. Genetic
predisposition and intensive sun exposure are risk factors for
melanoma development (Miller and Mihm, 2006). Despite world-
wide prevention efforts, melanoma incidence is increasing faster
than any other type of cancer (Miller and Mihm, 2006). Successful
treatment depends on early detection, as the metastatic form is
resistant to current therapies (Miller and Mihm, 2006).
The cascade of events driving metastasis is a highly regulated
multistep process, in which melanoma cells first proliferate within
the epidermis (radial growth phase (RGP)), then penetrate through
the dermal–epidermal junction, deeply invade the underlying
dermis (vertical growth phase (VGP)), enter the circulatory system
and colonise the target organ (Miller and Mihm, 2006). Although
the Breslow thickness of the primary tumour remains the single
most powerful prognostic factor, thin melanomas may develop
metastases, whereas thick melanomas may sometimes fail to
progress (Gimotty et al, 2004). Identifying biomarkers associated
with conversion from RGP to VGP in primary lesions is therefore
pivotal for early prediction of clinical outcome and development of
anti-invasive therapies.
Several studies have used microarrays for genome scale analysis
in clinical specimens and cell lines, especially to identify subsets
of genes that contribute to melanoma genesis and progression
(Bittner et al, 2000; Clark et al, 2000; Hoek et al, 2004; de Wit
et al, 2005; Haqq et al, 2005; Smith et al, 2005; Talantov et al,
2005; Winnepenninckx et al, 2006; Jaeger et al, 2007; Ryu et al,
2007). Interestingly, several research groups reported that
increased expression of genes involved in extracellular matrix
assembly and in regulating the cytoskeleton correlated with
higher metastatic capacity (Bittner et al, 2000; Clark et al, 2000;
Winnepenninckx et al, 2006). However, many of the model
systems used to study melanoma metastasis bypass the earliest
events, and especially dermal invasion. Consequently, this critical
first step in the metastatic process has been less well studied than
later stages.
A few recent studies point to a common metastasis signature
emerging as primary melanoma tumours thicken (Haqq et al,
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s2005; Winnepenninckx et al, 2006; Jaeger et al, 2007; Ryu et al,
2007), strengthening the concept that metastatic subpopulations of
cells pre-exist within a primary tumour (Fidler, 2002). In line with
this, we previously reported that subpopulations of melanoma
cells, selected from a non-aggressive parental cell line for their
ability to bind the peanut agglutinin lectin (PNA), generated lung
metastases when injected subcutaneously into neonatal immune-
suppressed rats (Dore ´ et al, 1994; Zebda et al, 1994, 1995). More
importantly, such PNA-positive cells are able to cross the dermal–
epidermal junction by degrading collagen IV and VII, and thus
colonise the dermis of human skin reconstructs (Be ´chetoille et al,
2000; Goidin et al, 2001). In sharp contrast, PNA-negative
melanoma cells only proliferate in the epidermis near the
basement membrane, without infiltrating the dermis (Be ´chetoille
et al, 2000; Goidin et al, 2001). These PNA-positive melanoma cells
actually exist in primary melanomas, and are associated with
the degree of local invasion, which in turn governs the risk of
metastases and poor clinical outcome (Berthier-Vergnes et al,
1993; Cochran et al, 1999). Taken together, these findings strongly
suggest that PNA-positive cells within the primary tumour are
those likely to invade dermis.
This study sought to identify candidate markers associated with
the acquisition of dermal invasiveness. Oligonucleotide micro-
arrays were used to discover genes that varied in expression level
between two well-characterised invasive PNA-positive vs non-
invasive PNA-negative melanoma cell clones, both selected in vivo
from a non-aggressive parental cell line (Boukerche et al, 1994,
2007; Zebda et al, 1994, 1995; Be ´chetoille et al, 2000). TSPAN8, a
member of the tetraspanin family, was thereby identified,
confirmed as exclusively expressed by melanoma cells from
a panel of invasive cell lines and functionally characterized as a
novel mediator of cutaneous melanoma invasion.
MATERIALS AND METHODS
Antibodies and reagents
Chemical reagents, primary and secondary antibodies used are
listed in Supplementary Materials and Methods.
Cell lines and cell culture
See Supplementary Materials and Methods for a detailed descrip-
tion of the cell lines used.
DNA microarray hybridisation and data analysis
Extracted RNA from IC8 and T1C3 clones was further amplified
using the AminoAllyl MessageAmp II aRNA amplification kit
(Ambion/Applied Biosystems, Austin, TX, USA). Four indepen-
dent dye-swap hybridisations (eight microarrays) were performed
as we have described elsewhere (Bonin et al, 2009). Further
experimental details, including microarray analysis, are described
in Supplementary Materials and Methods.
Semiquantitative RT–PCR
Semiquantitative PCR measurement of RELN, RNLS, CAPG, H2AFJ
and FXYD5 expression was carried out in a Peltier thermal cycler
(MJ Research Inc., Waltham, MA, USA). Primer sets and PCR
conditions are detailed in Supplementary Materials and Methods.
Quantitative real-time RT–PCR
Real-time PCR was performed on an Mx3000P real-time PCR
system (Stratagene, La Jolla, CA, USA). Primer sets, PCR
conditions and details of quantitation analysis are listed in
Supplementary Materials and Methods. Three biological replicates,
resulting from three different RNA extractions, were used for
quantification analysis, and three technical replicates were
analysed for each biological replicate.
Western blot analysis
Subconfluent melanoma cell monolayers were washed with PBS
and detached from the flask by a Cell Dissociation Buffer enzyme-
free solution (Invitrogen Co., Carlsbad, CA, USA). Cells were lysed
for 30min at 41C in RIPA buffer (50mM Tris-HCl, pH 8.0, 150mM
NaCl, 0.5% sodium deoxycholate, 1% NP40, 0.1% SDS) and
supplemented with protease inhibitors (Complete Mini; Roche
Diagnostics, Mannheim, Germany). Protein concentration was
assayed using the DC protein assay kit (BioRad Laboratories, Inc.,
Benicia, CA, USA). Equal amounts of protein (10mg) were
separated on 10% SDS–polyacrylamide gel under non-reducing
conditions, then transferred onto PVDF membrane. Membranes
were blocked for 1h at room temperature with 10mM Tris-Buffer
Saline, containing NaCl 300mM, 1% Tween 20 and 10% non-fat
milk, and then incubated overnight at 41C with an antibody against
human CAPG or TSPAN8. After washing, membranes were further
incubated 1h at room temperature with a peroxidase-conjugated
goat anti-mouse antibody (Calbiochem, San Diego, CA, USA).
Reactive bands were detected by enhanced chemiluminescence
following the manufacturer’s suggestions (ECL; GE Healthcare Life
Sciences, Saclay, France), followed by a short exposure to X-ray film.
Flow cytometry
Cell surface staining for FXYD5, TSPAN8, CD9, CD53, CD63, CD81,
CD82, CD151, RELN and intracellular staining for BCL11A, CAPG,
renalase and ID3 were carried out according to a procedure detailed
in Supplementary Materials and Methods. The results are reported as
mean fluorescence intensity of three independent experiments.
Immunohistochemical analysis of normal skin and
melanoma tissues
Formalin-fixed, paraffin-embedded melanocytic lesions, pre-
viously classified according to their tumour growth phase (RGP,
VGP, metastasis), were screened for TSPAN8 protein expression by
a biotin–streptavidin-amplified technique with an alkaline phos-
phatase kit (Dako-LSAB2-System, DAKO, Hamburg, Germany).
Details of lesions and staining procedure can be found in
Supplementary Materials and Methods.
TSPAN8 gene knockdown with siRNA
T1C3 melanoma cells were seeded into six-well plates at 2 10
5
cells per well, grown for 24h in complete medium and then
transfected with ON-TARGET plus Smart pool siRNA specific to
TSPAN8 or scrambled siRNA-negative control (Dharmacon,
Chicago, IL, USA) at a final concentration of 5nM using Hyperfect
transfection reagent (Qiagen, Courtaboeuf Cedex, France)
according to the manufacturer’s directions. To check TSPAN8
knockdown, cells were harvested 2, 3, 4, 5 and 6 days after siRNA
transfection and analysed by RT–qPCR, western blot and flow
cytometry as described above. Toxicity due to transfection was
excluded, as assessed by flow cytometry using propidium iodide
(Sigma, St Louis, MO, USA). Three days after transfection, cells
were detached by accutase and used for cell viability, proliferation,
migration and invasion assays, as described below.
Cell proliferation and viability assays
BrdU incorporation was used to determine cell proliferation. Cell
viability was determined by means of a colorimetric XTT assay.
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Methods.
Migration assay
Migration of melanoma cells was assessed using a mechanical
scratch wound assay as described elsewhere (Boukerche et al,
2007). The experimental procedure and the quantification analysis
are detailed in Supplementary Materials and Methods.
Three-dimensional spheroid invasion assay
Spheroid cell culture was performed using the hanging drop
method, as described previously (Smalley et al, 2006). Further
experimental details and invasive outgrowth quantification are
given in Supplementary Materials and Methods. Two separate
experiments were run in quadruplicate.
Statistical analysis
The results were analysed for statistical significance using
Student’s t-test. Only P-values o0.05 were considered statistically
significant (*Po0.05, **Po0.01, ***Po0.001).
RESULTS
Gene expression differences between invasive and
non-invasive melanoma cells
To identify genes involved in the acquisition of an invasive
potential, the gene expression profiles of invasive PNA-positive
(T1C3 clone) and non-invasive PNA-negative (IC8 clone)
melanoma cells, selected from the same parental cell line
(Berthier-Vergnes et al, 1993; Zebda et al, 1994, 1995; Be ´chetoille
et al, 2000; Goidin et al, 2001), were compared using oligonucleo-
tide microarray. Of the 26496 genes analysed (2% of probes
spotted on microarray) 461 were differentially expressed between
the two clones (fold-change p2, Student’s t-test P-value o0.01):
390 of these were downregulated in the invasive (T1C3 clone)
melanoma cells, whereas only 71 were upregulated (Supplementary
Tables S1, S2). Down- and upregulated genes implicated in major
diseases and disorders or major molecular and cellular functions
are listed in Supplementary Tables S3 and S4, respectively. As
expected, the largest numbers of these regulated genes were those
associated with cancer, inflammation and dermatological diseases
(Supplementary Tables S1 and S3). Interestingly, the genes
expressed most differentially between the two clones were involved
in cell growth and death control, cell movement and invasion, cell
assembly and organisation, cell-to-cell interaction, as well as DNA
replication, recombination and repair (Supplementary Tables S1
and S4). Further analysis revealed that most of these genes
critically regulated cell cycle, apoptosis, cell adhesion, cytoskeleton
organisation, proteolysis and the intracellular signalling cascade.
Putative biological markers of dermal invasiveness are those
genes that are overexpressed in invasive melanoma cells. Most are
critically involved in the regulation of cell movement and invasion,
as well as proliferation (Supplementary Tables S1 and S4). Some of
them encode for proteins involved in cell adhesion and actin-based
motility, including ICAM2, a2-actin (ACTA2), autocrine motility
factor/glucose phosphate isomerase, extracellular matrix serine
protease (RELN), pigment epithelium-derived factor (SERPINF1),
a tetraspanin family member (TSPAN8) and CAPG (capping
protein-actin filament-gelsolin-like) (Supplementary Table S4),
highlighting the well-known importance of tumour cell interaction
with the extracellular matrix during invasion. In line with this,
integrin signalling emerged as one of the top relevant biological
pathways (Ingenuity score¼2.65E–03). Furthermore, ERK/MAPK
(Ingenuity score¼9.38E–03) was the second top signalling
pathway, known to have a key role in the pathogenesis of
cutaneous melanoma (Meier et al, 2005), thus confirming the
reliability of our study design.
Validation of microarray candidate genes
Transcripts that are up- rather than downregulated in invasive
cells may have potential prognostic and therapeutic relevance. We
therefore focused on the genes that exhibited the greatest fold-
change (42.8) (Supplementary Table S2). Ingenuity pathways
analysis highlighted that cancer and cellular movement/invasion
were the functional classes most consistently found to be enriched
in this set of genes (Supplementary Tables S3 and S4). We thus
excluded genes unrelated to cancer and those related to cancer, but
not to cellular movement/invasion (Supplementary Tables S3 and
S4). Among them, SERPINF1 was excluded because it encodes the
secreted epithelium-derived factor (PEDF), also found in normal
melanocytes (Orgaz et al, 2009). RNLS encoding renalase, a
recently discovered secreted amine oxidase involved in kidney
disease, was included, as amine oxidases are well-known regulators
for cancer progression. H2AFJ, encoding a member of the histone
H2A family, was also included, as a previous cDNA microarray
study of a melanoma model had found it to be upregulated in
metastatic cells (de Wit et al, 2005). Finally, seven genes were
selected for further validation: BCL11A, CAPG, RELN, TSPAN8,
ID3, FXYD5 and RNLS.
BCL11A, the B-cell associated transcription factor leukaemia
11A gene encoding a zinc-finger protein, acts as a transcriptional
repressor critical to lymphoma malignancy (Satterwhite et al,
2001). CAPG encodes an actin filament end capping of the gelsolin
family crucial for the control of cell migration or invasion in a
variety of cancer cells (Renz et al, 2008). RELN encodes reelin,
a matrix serine protease regulating neural cell migration and tumour
progression (Perrone et al, 2007). TSPAN8 encodes tetraspanin 8,
also known as CO-029, a transmembrane protein overexpressed in
numerous carcinomas (Boucheix et al, 2001; Hemler, 2005; Zo ¨ller,
2009). ID3 gene encodes a protein DNA-binding protein inhibitor,
overexpressed in several carcinomas and reported to be involved
in tumour growth, invasiveness, metastasis and angiogenesis
(Lasorella et al, 2001). FXYD5 encodes dysadherin, a cancer-
associated glycoprotein that promotes tumour metastasis by
downregulating E-cadherin in numerous human carcinomas
(Ino et al, 2002).
To further validate microarray data, transcript levels of the
selected genes were measured by RT–PCR. Semiquantitative
RT–PCR results for CAPG, FXYD5, RNLS, RELN and H2AFJ
(Figure 1A) and real-time quantitative PCR results for ID3,
BCL11A and TSPAN8 (Figure 1B) were consistent with the
microarray data. The upregulation of these genes in T1C3
melanoma cells was also confirmed in two other experiments,
using RNA extracts from both clones cultivated for different
numbers of passages (data not shown).
TSPAN8 and CAPG proteins were highly expressed in T1C3
melanoma cells
To validate mRNA expression, the expression levels of the selected
gene products on IC8 and T1C3 cells were compared by flow
cytometry. Melanoma cells were surface stained for TSPAN8,
RELN and FXYD5 or intracellularly stained for renalase, CAPG,
BCL11A and ID3. As shown in a representative experiment
(Figure 2A), BCL11A, ID3, renalase and RELN were expressed at
similar levels in both clones. In contrast, TSPAN8, CAPG and
FXYD5 expressions were markedly higher in T1C3 than IC8 cells.
Figure 2B summarises the results from three independent
experiments, confirming that only TSPAN8 and CAPG were
significantly overexpressed in T1C3 compared with IC8 cells.
Indeed, T1C3 cells exhibited an approximately 11- and 4-fold cell
TSPAN8 as a novel mediator of invasion
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IC8 cells. The differential expression of these two proteins was
further confirmed by western blot analysis (Figure 2C). It should
be noted, however, that TSPAN8 was so weakly expressed in IC8
melanoma cells that no band could be visualised (Figure 2C).
Taken together, these results show that TSPAN8 and CAPG were
more highly expressed at both mRNA and protein levels in T1C3
than in IC8 cells.
TSPAN8 was the only tetraspanin in which overexpression
correlated with the invasive phenotype
We then investigated the expression of TSPAN8 and CAPG protein
on another seven melanoma cell lines/clones, in addition to the
two clones, to find any correlation with the invasive potential of
melanoma cells. These cell lines and clones, widely used as a
metastasis melanoma model (Dore ´ et al, 1994; Zebda et al, 1994,
1995; Be ´chetoille et al, 2000; Goidin et al, 2001; Boukerche et al,
2007), were classified into two groups: (a) PNA-moderate or
-negative cells with low or no invasive potential: M4Be, T1C11,
M3Ge, M3Da and M1Do; and (b) PNA-positive cells with a high
invasive potential: TW12 and T1P26. Flow cytometry demon-
strated that CAPG was expressed not only by cells belonging to the
non-invasive group, especially the M4Be, M3Ge, M1Do cell lines,
but also by TW12 clone from the invasive group (Figure 3A). In
contrast, TSPAN8 was exclusively expressed by cells belonging to
the invasive group. The correlation between TSPAN8 expression
and aggressiveness was not restricted to our melanoma model, as
SKMel28 and WM793 melanoma cell lines, chosen because they are
able to invade dermis in human skin reconstructs (Hsu et al, 2008;
Lasithiotakis et al, 2008), also expressed TSPAN8 on their cell
surface (Figure 3A).
Because previous research indicated that tetraspanins may
contribute to the metastatic process (Boucheix et al, 2001; Hemler,
2005; Zo ¨ller, 2009), we next analysed the cell surface expression
profiles of other tetraspanins (CD9, CD53, CD63, CD81, CD82 and
CD151) on invasive and non-invasive melanoma cells. As shown in a
representative experiment (Supplementary Figure S1), TSPAN8 was
the only tetraspanin able to distinguish between invasive and non-
invasive cells. Importantly, TSPAN8 was not expressed on normal
melanocytes (Supplementary Figure S1). Therefore, the cell surface
expression of TSPAN8, but not that of CAPG, was associated with the
invasive behaviour of a panel of melanoma cells in culture.
TSPAN8 was expressed in primary melanomas and in
lymph node metastases, but not in normal epidermis
Despite the observation of TSPAN8 overexpression in various
carcinomas (Boucheix et al, 2001; Hemler, 2005; Zo ¨ller, 2009), no
information is available for human cutaneous melanoma. We
therefore further examined in situ TSPAN8 expression in melano-
cytic lesions. Immunohistochemistry was performed on archival
formalin-fixed, paraffin-embedded sections of tissue ranging from
normal skin to benign tumour, as well as invasive and metastatic
melanocytic lesions. The samples covered all major types of
melanocytic proliferation, including 16 benign nevi (8 congenital,
8 compound), 13 primary melanomas in RGP, 35 primary mela-
nomas that had entered VGP and 6 melanoma metastases to lymph
nodes. Normal skin was not stained by anti-Tspan8 and half of
benign lesions showed a weak staining in few nevus cells (Figure 3B;
Supplementary Table S5). In contrast, melanoma cells stained
strongly positive for TSPAN8 in primary melanomas and in lymph
nodes (Figure 3B): immunoreactivity was observed in 8 of the 13
RGP lesions, in 10 of the 35 VGP lesions and in 2 of the 6 lymph
node metastases (Supplementary Table S5). Numerous positive cell
nests were located near the dermal–epidermal junction in both the
intraepidermal and the dermal components of the primary lesions
(Figure 3B). At higher magnification, cytoplasm and membrane
staining of varying intensity could be observed in primary and
metastatic melanoma lesions.
Transient endogenous TSPAN8 knockdown did not
significantly impair cell survival, proliferation or cell
migration
Although several tetraspanins have been implicated as regulators
of cell proliferation, migration and invasion of tumour cells
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Figure 1 Reverse transcription–polymerase chain reaction (RT–PCR)
analysis of eight selected genes differentially expressed in invasive (T1C3)
and non-invasive (IC8) clones, according to microarray analysis.
(A) Semiquantitative PCR was performed with total RNA isolated from
both clones. PCR products were loaded on a 1.2% agarose gel and stained
with ethidium bromide. The expected length of PCR products is indicated
on the right. The data are representative of three experiments.
(B) Quantitative RT–PCR analysis of three genes in T1C3 cells compared
with IC8 cells. Copy number was first normalised to 18SRNA levels and
expressed as the fold-change over IC8 cells. The graph depicts the mean of
these fold-changes ±s.d. of three independent amplifications.
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TSPAN8 is still unknown. To examine whether it was also involved
in these cellular processes, we first knocked down endogenous
TSPAN8 by transient transfection of invasive T1C3 cells with
specific siRNA. As shown in Figure 4, the TSPAN8 silencing effect
was efficient: a strong reduction of both TSPAN8 mRNA and
protein expression was confirmed with TSPAN8-targetting siRNA
as early as 2 days after transfection and persisted for up to 5 days,
as assessed by qRT–PCR (Figure 4A), western blot (Figure 4B) and
flow cytometry (Figure 4C and D). Mean silencing of TSPAN8
transcripts averaged 89±4.6 and 72±5.8% at 2 and 5 days post-
transfection, respectively (n¼3), without significant impact on the
expression of other two major tetraspanins expressed by both
melanoma clones: CD9 and CD151 (Figure 4C and D), thus
demonstrating the specificity of the silencing effect.
We next sought to determine the role and significance of
endogenous TSPAN8 silencing on melanoma cell viability and
proliferation. As shown in Figure 5A, the reduced expression of
TSPAN8 in invasive melanoma cells did not alter cell viability, as
evaluated by XTT assay. Likewise, the cell proliferation measured
by BrdU ELISA assay did not reveal any significant disturbance
(Figure 5B). Furthermore, TSPAN8 silencing was not accompanied
by changes in cell morphology (not shown).
The correlation between TSPAN8 expression and the invasive
phenotype led us to examine whether this protein was critical to
the migratory behaviour of melanoma cells. As illustrated in a
representative experiment (Figure 5C), 28h after a wound had
been generated in a confluent cell monolayer, closure was almost
complete in both silenced and scrambled T1C3 cells. Quantitative
analysis of the areas recolonised by the cells in three independent
experiments confirmed that the reduced expression of TSPAN8 did
not significantly alter the migration rate (Figure 5D). As additional
controls, T1C3 cells displaying endogenous TSPAN8 and IC8 cells
devoid of TSPAN8 were also examined and found to exhibit similar
migratory behaviour (data not shown).
Because several studies have reported tetraspanins involve-
ment in cell–matrix interactions, scratch wound assay was
also performed on cells plated on the two main components of
the basement membrane and dermis (type IV- or type I-collagen,
respectively) and on a reconstituted basement membrane
(matrigel). No significant impairment in wound closure was detected
between melanoma cells transfected with TSPAN8-specific or
scramble siRNAs in the presence of either type of collagen
(Figure 5C and D), as well as on matrigel (data not shown).
Transient endogenous TSPAN8 knockdown reduced the
invasive outgrowth of melanoma cells embedded in
matrigel
It is now acknowledged that three-dimensional (3D) spheroid
culture more accurately mimics the tumour microenvironment
than two-dimensional (2D) monolayer culture (Smalley et al, 2006;
Pampaloni et al, 2007). Therefore, T1C3 melanoma cells were
grown as cellular spheroids in a 3D matrix, a well-known model
system previously shown to adequately reflect melanoma stage
(RGP, VGP or metastatic) (Smalley et al, 2006). As illustrated in a
representative experiment (Figure 6A), the multicellular aggregates
of melanoma cells formed a cell-dense region, analogous to the
core of the primary tumour. Importantly, T1C3 transfected with
scramble or TSPAN8-specific siRNA and untransfected cells all
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Figure 2 TSPAN8 and CAPG are strongly upregulated in T1C3 invasive melanoma cells. Invasive (T1C3) and non-invasive (IC8) melanoma cells were cell
surface stained with mAbs directed against TSPAN8, RELN and FXYD5, and intracellularly stained with anti-CAPG, BCL11A, ID3 and renalase. (A) Data
from a representative experiment showing flow cytometry profile of IC8 and T1C3 melanoma cells stained with the indicated mAbs. Filled histograms
represent specific and open histograms isotype-matched control antibodies. (B) Results for a given protein are expressed as the following ratio: MFI in T1C3/
MFI in IC8 cells ±s.d. of three independent experiments. Statistical significance was assessed using Student’s t-test: ***Po0.001. (C) Total cell lysates from
IC8 and T1C3 were subjected to western blot analysis with antibodies specific for CAPG and TSPAN8, actin serving as a loading control.
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Relative mRNA expression of TSPAN8 in different cell lines was normalised to the signal intensity of 18S RNA as an internal control. A representative experiment of
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or actin at the indicated days after transfection. (C) Melanoma cells were cell surface stained using the indicated mAbs at day 3 after transfection. Data from a
representative experiment showing flow cytometry profile of cells transfected with scramble (black) or TSPAN8 (white) siRNAs. Mean fluorescence intensity is
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Figure 3 TSPAN8 is expressed by invasive melanoma cells in culture and in melanoma lesions. (A) Non-invasive (M4Be, M3Ge, M3Da, M1Do cell lines and IC8,
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sformed compact spheroids that increased in size over 3 days,
corroborating the finding that TSPAN8 is not required for
melanoma growth. However, T1C3 cells transfected or not with
scramble siRNA exhibited spheroids that progressively infiltrated
the surrounding matrigel matrices, mimicking invading cells
(Figure 6A). In contrast, TSPAN8-knockdown spheroids showed
restrictive invasive movement away from the spheroid edge
(Figure 6A). Quantitation of invasive outgrowth indicated that
the total spheroid surface area of TSPAN8 siRNA-transfected cells
significantly decreased nearly 1.8-fold compared with scramble
siRNA-transfected cells or untransfected cells at day 3 (Figure 6B).
Altogether, these results indicate that TSPAN8 has a role in the
invasive behaviour of melanoma cells.
DISCUSSION
The alterations that allow progressive invasion into the dermis
remain ill defined, largely due to the limited availability of primary
tissues, their heterogeneous nature, the interindividual genetic
variability of tissue specimens and derived cell lines, and the lack of
suitable experimental models. There have, therefore, been few true
advances towards the development of reliable diagnostic and
prognostic biomarkers in cutaneous melanoma (Ohsie et al, 2008).
We therefore compared global gene expression profiles of two
clonal subpopulations selected from the same human melanoma
cell line, but differing in ability to cross the dermal–epidermal
junction in skin reconstructs (Be ´chetoille et al, 2000; Goidin et al,
2001). The study spotlighted TSPAN8, a member of the tetraspanin
family, showing it to be strongly expressed, at both mRNA and
protein levels, by invasive melanoma cells as compared with
normal melanocytes or non-invasive melanoma cells. Its cell
surface expression correlated with the invasive phenotype of a
panel of melanoma cell lines. Consistent with the in vitro findings,
TSPAN8 was also expressed by melanoma cells in primary tumours
and lymph node metastases, but not in healthy epidermis. More
importantly, the functional role of TSPAN8 was demonstrated by
silencing endogenous TSPAN8 with siRNA, which reduces invasive
outgrowth from tumour spheroids within matrigel, without impact
on the cell proliferation and survival. To the best of our knowledge,
this is the first study to report that TSPAN8 is likely to have a
critical role in cutaneous melanoma invasion.
The transition from RGP to VGP is considered to be the high
point of change in gene expression patterns during melanoma
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Figure 5 Endogenous TSPAN8 silencing has no impact on cell survival, proliferation and migration. T1C3 melanoma cells were transfected with siRNA
targeting TSPAN8 (siTSPAN8) or siRNA scramble (scramble). (A) Cell viability determined by XTT assay 3 days post-siRNA treatment of T1C3 melanoma
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sprogression (Haqq et al, 2005; Smith et al, 2005; Jaeger et al, 2007;
Jensen et al, 2007; Riker et al, 2008), consistent with tumour
thickness being one of the strongest predictors of metastatic
disease and adverse clinical outcome (Miller and Mihm, 2006;
Ohsie et al, 2008). This study used well-characterised melanoma
cell populations, previously selected from a parental cell line
(Bailly and Dore ´, 1991) and differing in their ability, to invade
dermis in human skin reconstructs (Be ´chetoille et al, 2000; Goidin
et al, 2001). Notably, PNA-positive melanoma cells (T1C3 clone)
grew in a pattern resembling RGP lesions, whereas PNA-negative
cells (IC8 clone) displayed a VGP growth pattern: the former
invaded and proliferated deep in the dermis, whereas IC8 cells
remained in the epidermis (Be ´chetoille et al, 2000; Goidin et al,
2001). A large-scale oligonucleotide microarray comparative
transcriptome analysis of PNA-positive and PNA-negative mela-
noma cells was performed. These two cell populations were
unlikely to show the genetic heterogeneity that can complicate the
interpretation of microarray data. Indeed, few genes were
differentially expressed (2%), 390 of which were downregulated
and only 71 upregulated in the invasive melanoma cells.
Interestingly, the microarray data revealed less upregulated than
downregulated genes in the invasive melanoma cells. This is
consistent with data from other studies (Haqq et al, 2005;
Winnepenninckx et al, 2006; Jaeger et al, 2007; Ryu et al, 2007),
in which the switch from RGP to VGP was mainly accompanied by
loss of gene expression, validating our experimental model.
TSPAN8 belongs to a large family of integral membrane
proteins, the tetraspanins, characterised by the presence of four
highly conserved transmembrane domains. Also known as C0-029
in humans and D6.1 in rats, TSPAN8 was first identified as a
tumour-associated antigen present at high levels in several types of
human carcinoma and sarcoma (Boucheix et al, 2001; Zo ¨ller,
2009). Its overexpression correlates with gastrointestinal and
pancreatic cancer progression, thus representing a marker of poor
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Figure 6 Endogenous TSPAN8 silencing reduces melanoma cell invasion. T1C3 melanoma cells transfected with siRNA targeting TSPAN8 (siTSPAN8),
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in three-dimensional matrigel immediately after seeding (day 0) and at day 3. (B) Invasive outgrowth was quantified by calculating the ratio between the area
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sprognosis (Boucheix et al, 2001; Zo ¨ller, 2009). Here, we show for
the first time that TSPAN8 is strongly expressed in human
cutaneous melanoma. Interestingly, TSPAN8 was not constitutively
expressed by normal melanocytes, in contrast to nevocytes and
melanoma cells from primary and metastatic lesions. This suggests
that the expression of TSPAN8 occurs very early during tumour
development.
It was initially thought that invasion and dissemination
occurred during the VGP. However, gene profiling studies by
several research teams strongly suggest that invasive potential may
exist early in melanoma development (Hoek et al, 2004; Haqq et al,
2005; Talantov et al, 2005; Riker et al, 2008). In support of
this theory, Eyles et al (2010) recently demonstrated, in a mouse
melanoma model, that melanoma cells emigrate to remote organs
very early during the development of the primary tumour. Here,
we found a higher frequency of TSPAN8 expression in early (RGP)
than later stages of melanoma progression (VGP, metastatic).
Although further studies on larger series of melanocytic lesions
will be necessary to confirm these findings, the idea of early spread
led us to speculate that TSPAN8 might identify metastatic cells
arising from early primary tumours.
The tetraspanins have a unique ability to associate laterally with
one another and to cluster dynamically with other transmembrane
and signal-transducing partners, notably, integrins (Boucheix et al,
2001; Hemler, 2005; Zo ¨ller, 2009). Through these multimolecular
complexes, several tetraspanins are thought to mediate steps of the
metastatic cascade. Claas et al (2005) reported that D6.1A
associates with tetraspanins CD151, CD9, CD81, integrins a3b1
and a6b4, and also with other partners, including EWI-F and
EpCAM, on rat carcinoma cells. Le Naour et al (2006) found that
TSPAN8 was detected by mass spectrometry only in CD9
complexes collected from high invasive colon carcinoma. Further-
more, several tetraspanins may also associate with non-protein
partners, such as gangliosides (Kawakami et al, 2002). We found
here that TSPAN8 was the only tetraspanin able to distinguish
invasive from non-invasive melanoma cells. Because PNA-positive
cells display a peculiar cell surface profile of integrins (Boukerche
et al, 1994) and gangliosides (Zebda et al, 1995), identifying
TSPAN8 partners in invasive human melanoma cells is therefore
essential for understanding the functions conferred by TSPAN8,
and is currently under investigation.
Very little is known about the mechanisms of TSPAN8-mediated
metastasis promotion. It is thought that TSPAN8 contributes to the
cell motility of metastatic carcinoma cell lines, mostly through its
association with a6b4 and CD151 following PMA treatment
(Herlevsen et al, 2003; Gesierich et al, 2005), whereas association
with a3b1 and a6b1 promotes haematogenic spread of tumour cells
(Claas et al, 1998; Kanetaka et al, 2003). An interesting finding in
this study is that siRNA TSPAN8 knockdown reduced the invasive
outgrowth of melanoma spheroids embedded in matrigel. It seems
unlikely that this was caused by a decrease in cell survival or
growth rate, as TSPAN8 silencing did not affect viability or
proliferation. Our observations are in line with previous studies
showing that ectopic TSPAN8 expression in low-metastatic
carcinoma cells did not confer any advantage for cell proliferation
but led to a high metastatic potential (Claas et al, 1998; Kanetaka
et al, 2003; Zhou et al, 2008).
Three-dimensional models of melanoma culture represent a
technical approach that adequately reflects the clinical melanoma
tumour stage: cell lines derived from VGP, but not RGP, melanoma
lesions invade 3D matrices (Smalley et al, 2006). Therefore,
we here used melanoma spheroids embedded in a basement-
membrane-like extract (matrigel) to mimic the invasive movement
of melanoma cells through the basement membrane. Although
TSPAN8 silencing reduced the invasive outgrowth of melanoma
cells embedded in matrigel, it did not impair their ability to close
an artificial gap created over a confluent monolayer, even when
cells were grown on plates coated with collagen-IV (the main
basement membrane component), collagen-I (the most abundant
component of the dermis) or a recontituted basement membrane:
matrigel. These unexpected findings were consistent with the
notion that the invasive capacity of tumour cells studied in 3D
systems is not necessarily correlated with efficient migration on
planar 2D surfaces (Torka et al, 2006). This is not surprising, given
that the engagement of integrins (the main partners of tetra-
spanins) with matrix proteins was differentially regulated in the
2D relative to the 3D context (Cukierman et al, 2001). Indeed, the
2D- and 3D-matrix–integrin adhesion structures strongly differed
in composition, thus recruiting of distinct cytoskeleton and
cytoplasmic proteins, which control signalling pathways, and
therefore, the mode of cell migration (Doyle et al, 2009). Given that
the migratory/invasive behaviour of melanoma cells cultured in a
3D environment required a Rho GTPase protein (Klein and Aplin,
2009), further studies will be needed to investigate whether
TSPAN8-mediated invasion is dependent on Rho signalling.
In conclusion, the present findings highlight several new aspects
of the role of TSPAN8 in the initial steps of human melanoma
progression. If the present in vitro findings have any physiological
relevance, it is thus conceivable that TSPAN8 expression might
give melanoma cells the ability to cross the cutaneous basement
membrane, an early event leading to dermal invasion and
progression to metastatic disease. Although much is yet to be
learned regarding the clinical relevance of its function, we
postulate that TSPAN8 could be a promising new therapeutic
target in anti-invasive therapies for cutaneous melanoma.
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